Cannabidiol or CBD has been at the heart of the cannabis revolution. The hemp extract is one of the over 100 cannabinoids found in hemp, and it doesn’t get users intoxicated. That honor belongs solely to THC (delta-9 tetrahydrocannabinol), the main psychoactive agent in marijuana. CBD, on the other hand, outshines THC in an entirely different way.
Over the years, anecdotal evidence has surfaced painting the compound as an astonishingly potent medicine. It has proven effective against tons of medical conditions such as insomnia, chronic pain, and high blood pressure. Last year, the U.S. Food and Drug Administration (FDA) even…
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire is part of the InvestorBrandNetwork.